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Purpose: ST2 receptor, which is a member of the Toll-like/interleukin-1 (IL-1) receptor family, 
has been found to be increased in the serum of patients 1 day after myocardial infarction. Several 
other studies have shown that soluble ST2 levels correlate with severity of heart failure (HF), 
left ventricular ejection fraction, creatinine clearance, B-type natriuretic peptide and C-reactive 
protein, and are predictors of mortality in HF. Most of these studies were not only limited to 
ischemic heart disease but also concentrated on left-sided HF. We therefore decided to study 
the relationship between soluble ST2 and some markers of right ventricular (RV) function in a 
cohort of hypertensive HF subjects.
Patients and methods: This is a prospective cohort study of hypertensive HF patients 
presenting to the University of Abuja Teaching Hospital, Abuja, over a 12-month period. ST2 
was measured in plasma sample by the enzyme-linked immunosorbent assay (ELISA) method. 
Right ventricular diameters in diastole (RVDD) and right atrial area (RAA) were obtained on 
echocardiography, while right ventricular systolic pressure (RVSP) was estimated from echocar-
diography by the addition of the pressure gradient between the right ventricle and right atrium 
(RA) to the pressure in the RA.
Results: There was a significant correlation between RVSP and soluble ST2 (t=0.75, p<0.0001), 
RVDD (t=0.28, p=0.004) and RAA (t=0.46, p=0.002).
Conclusion: In a cohort of hypertensive HF subjects, soluble ST2 correlates significantly with 
RVSP, RVDD and RAA.
Keywords: RV function, ST2, hypertensive heart failure
Introduction
ST2 receptor is a member of the Toll-like/interleukin-1 (IL-1) receptor family with 
research works in animal models showing that cytokine IL-33 interacts with ST2 recep-
tors in cardiac myocytes, thereby comprising a cardioprotective stress-responsive signal-
ing system.1 ST2 is induced in conditions of myocardial overload, such as myocardial 
infarction, when the remaining viable myocardium must bear more stress.1 Soluble ST2 
has been found to be increased in the serum of patients 1 day after myocardial infarction, 
and its serum levels predict outcome in patients with heart failure (HF).2 Several other 
studies have shown that soluble ST2 levels correlate with severity of HF, left ventricular 
ejection fraction (LVEF), creatinine clearance, B-type natriuretic peptide and C-reactive 
protein, and are predictors of mortality.3,4 In addition, soluble ST2 has also been found 
to be a useful biomarker in differentiating the various spectra of hypertensive heart dis-
ease.5 Most of these findings, however, were limited to not only ischemic heart disease 
but also left-sided HF. We therefore decided to study the relationship between soluble 
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ST2 and some markers of right ventricular (RV) function in 
a cohort of hypertensive HF subjects of a population where 
hypertension is the commonest cause of HF.6,7 
Patients and methods
Subjects
This prospective cohort study was approved by the ethical clear-
ance committee of the University of Abuja Teaching Hospital 
and is in compliance with the Declaration of Helsinki, and, 
wherever possible, it also adheres to the STROBE (STrength-
ening the Reporting of OBservational studies in Epidemiol-
ogy) guidelines for an observational study of this kind. The 
minimum age for participation in the study was 18 years, but 
there was no upper age limit. Of the 81 patients enrolled for the 
study, four (4.9%) of the total enrolment was excluded because 
patients were diabetic, had regional wall motion abnormality 
on transthoracic echocardiography, had serum creatinine lev-
els >170 µmol/L or had previous acute myocardial infarction. 
Therefore, 77 subjects with hypertensive HF were studied. 
Hypertension was defined according to the Joint National Com-
mittee VII guidelines.8 The subjects also had clinical features of 
long-standing hypertension, which included thickened arterial 
wall, locomotor brachialis and at least Grade 2 hypertensive 
retinopathy. HF was diagnosed according to the guidelines of 
the European Society of Cardiology.9 The functional status of 
the HF subjects was according to the guidelines of New York 
Heart Association Functional Classification.10 All subjects gave 
written informed consent to participate in the study.
Questionnaire
All the subjects completed a standard questionnaire. Owing 
to the multiplicity of languages in Nigeria, the question-
naire was not translated into any of the local languages. The 
majority of the subjects were reasonably proficient in English 
language. Where there was a need for interpretation, both 
medical and paramedical staff of the Cardiology Unit of 
the Department of Medicine of University of Abuja Teach-
ing Hospital assisted. The questionnaire requested specific 
answers regarding date of birth, gender, occupation, back-
ground diagnosis of hypertension, background diagnosis of 
diabetes mellitus, history of angina pains, history of alcohol 
consumption and history of smoking habits.
Anthropometric measurements and 
conventional blood pressure (BP) 
measurements
The height and weight of the subjects were measured in the 
clinic by nursing staff with the participants standing and wear-
ing indoor clothes with no shoes. Body mass index was calcu-
lated as weight in kilograms divided by the square of height in 
meters. Body surface area in square meter (m2) was calculated 
as (0.0001)×(71.84)×(weight in kg)0.425×(height in cm)0.725.
BP measurements were obtained according to the 
standard guidelines with a mercury sphygmomanometer 
(Accoson, London, UK). Systolic BP and diastolic BP were 
measured by cardiologists at Korotkoff sounds I and V, 
respectively. BP was measured at the right arm three times 
after a 5-minute rest with the patient in the sitting position, 
and the average of the three measurements was obtained. 
Pulse pressure was calculated as systolic BP minus diastolic 
BP, while mean arterial pressure was calculated as one-third 
of diastolic BP plus pulse pressure.
Blood measurements
Blood samples were collected for fasting blood sugar, fasting 
lipid profile, electrolyte, urea and creatinine and full blood 
count and for NT-proBNP and ST2 assay. The blood was put 
into EDTA tubes, and the samples were immediately centri-
fuged and plasma separated and then stored at -80°C until 
assayed. Samples were transported in dry ice and shipped 
to the Hatter Institute of Cardiovascular Research in Africa; 
the assay was carried. Details of NT-proBNP and ST2 assay 
have been described in our previous publication.11
Transthoracic echocardiography
Echocardiography was performed using a commercially avail-
able ultrasound system (IVIS-60). Details of echocardiography 
have been previously reported in a similar paper by authors.12
Data analysis
SPSS software version 16.0 (SPSS Inc., Chicago, IL, USA) 
was used for statistical analysis. Continuous variables were 
expressed as mean ± SD. Comparison of demographic, clini-
cal, laboratory and echocardiographic parameters among the 
three groups was performed by analysis of variance. Correla-
tion coefficients were calculated by linear regression analysis 
with serum NT-proBNP and soluble ST2 log transformed 
to establish normality, and correlations between tricuspid 
annular plane systolic excursion (TAPSE) and continuous 
demographic, clinical, laboratory and echocardiographic 
parameters were evaluated by Spearman regression.
Results
Clinical profile of the subjects
Table 1 shows the clinical profile of the subjects studied. The 
subjects were middle aged with mean age of 53.8±13.2years. 
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There was no significant difference between the ages of the 
male and female subjects; nor was there a difference in the 
body mass index between the male and female subjects. 
Men smoked more than women (18.6% versus 2.5%, p-value 
<0.0001) and had worse renal function with the estimated 
glomerular filtration rate of 111.6±41.4 mL/min versus 
78.3±17.0 mL/min in women (p-value <0.0001). The women 
presented more often with palpitations (57.7% versus 48.9%, 
p-value =0.02). Serum ST2 and NT-proBNP levels were 
similar in men and women.
Echocardiographic profile of the subjects
Table 2 shows the echocardiographic profile of the subjects. 
The male subjects had significantly more hypertrophy 
Table 1 Clinical profile of subjects
Parameters All (N=77) Male (n=54) Female (n=23) p-value
Age, years 53.8±13.2 53.8±15.8 51.7±13.6 0.56
Smoking habits, n (%) 24 (13.1) 22 (18.6) 2 (2.5) <0.001
Body mass index, kg/m2 24.30±7.0 24.2±7.6 24.5±5.9 0.86
Palpitations, n (%) 40 (51.9) 24 (44.4) 16 (69.6) 0.002
Peripheral edema, n (%) 49 (63.2) 35 (64.8) 14 (60.8) NS
NYHA class, n (%)
II 14 (18.2) 10 (18.5) 4 (17.5)
III 49 (63.6) 35 (64.8) 14 (60.8)
IV 14 (18.2) 9 (16.7) 5 (21.7)
SBP, mmHg 149.1±23.8 149.9±23.8 147.7±23.9 0.55
DBP, mmHg 98.1±13.9 98.2±13.9 97.9±13.9 0.92
PP, mmHg 55.8±16.2 56.4±16.8 54.7±15.0 0.52
MAP, mmHg 101.3±16.4 101.2±17.2 101.5±15.0 0.89
FBS, mmol/L 5.3±2.2 5.2±2.0 5.4±2.4 0.58
TC, mmol/L 4.2±1.2 4.1±0.2 4.3±1.2 0.22
LDLC, mmol/L 2.7±0.9 2.6±1.0 2.8±1.0 0.14
HDLC, mmol/L 1.1±0.4 1.1±0.4 1.1±0.3 0.63
Estimated GFR, mL/min/1.73 m2 101.5±38.8 111.6±41.4 78.3±17.0 <0.0001
NT-proBNP, pg/mL 501.7±199.8 513.0±208.5 478.7±184.7 0.58
Serum ST2, ng/mL 112.9±78.7 100.1±60.4 134.4±98.3 0.26
Note: Data presented as mean ± SD unless otherwise stated.
Abbreviations: NS, not significant; NYHA, New York Heart Association; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; MAP, mean 
arterial pressure; FBS, fasting blood sugar; TC, total cholesterol; LDLC, low-density lipoprotein cholesterol; HDLC, high-density lipoprotein cholesterol; GFR, glomerular 
filtration rate.
Table 2 Echocardiographic profile of subjects
Parameters All (N=77) Male (n=54) Female (n=22) p-value
RVDD, cm 3.4±0.6 3.5±0.6 3.2±0.5 0.22
Left atrium, cm 4.6±0.9 4.6±0.9 4.5±0.8 0.17
IVSD, cm 1.1±0.3 1.1±0.2 1.0±0.3 0.03
PWD, cm 1.1±0.2 1.2±0.2 1.1±0.2 0.07
EDD, cm 5.8±1.1 5.9±1.1 5.5±1.1 0.04
ESD, cm 4.7±1.3 4.9±1.2 4.5±1.3 0.07
LAA, cm2 24.5±7.0 24.5±6.7 24.4±7.5 0.95
RAA, cm2 22.3±8.1 22.6±8.0 21.7±8.5 0.50
LVM/HT2.7 108.3±46.3 117.5±35.4 112.5±42.3 0.65
LVEF, % 35.2±17.5 34.4±16.8 36.6±18.7 0.58
ME, m/s 0.78±0.3 0.76±0.30 0.81±0.30 0.43
MA, m/s 0.49±0.2 0.49±0.2 0.49±0.1 0.25
ME/MA 2.2±1.3 2.0±1.2 2.2±1.4 0.96
DT, ms 143.2±80.6 143.7±85.1 142.2±72.2 0.22
TAPSE, mm 16.2±5.1 16.6±5.4 15.5±4.5 0.16
TAPSE<15 mm, n (%) 33 (42.9) 54 (40.7) 10 (41.7) 0.18
RVSP, mmHg 31.4±10.5 31.4±10.4 31.3±10.5 0.97
Abbreviations: RVDD, right ventricular diameter in diastole; IVSD, interventricular septal diameter in diastole; PWD, posterior wall diameter in diastole; EDD, end-diastolic 
diameter; ESD, end-systolic diameter; LAA, left atrial area; RAA, right atrial area; LVM, left ventricular mass; HT, height; LVEF, left ventricular ejection fraction; ME, early 
mitral inflow; MA, late mitral inflow; DT, deceleration time; TAPSE, tricuspid annular plane systolic excursion; RVSP, right ventricular systolic pressure.
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involving the interventricular septal wall compared to the 
female subjects. They also had a more dilated left ventricle 
(LV), especially in diastole, compared to the female subjects. 
There was no gender difference in the LV mass indexed 
for height.2,7 Using TAPSE, 33 (42.9%) of the subjects had 
impaired RV systolic function.
Relationship between TAPSE and 
echocardiographic and laboratory 
parameters
Table 3 shows the relationship between RV systolic function 
as assessed by TAPSE and various echocardiographic and 
laboratory parameters. Left atrial diameter, areas of both 
atria, LV end-diastolic and end-systolic diameters, LV mass 
index, right ventricular systolic pressure (RVSP), LVEF and 
transmitral E/A ratio correlated significantly with TAPSE. 
There was no significant correlation between TAPSE and 
cardiac biomarkers.
Univariate association between log-
transformed ST2 and echocardiographic 
right-sided parameters
Table 4 shows that soluble ST2 correlates significantly with 
RVSP, right ventricular diameter in diastole (RVDD) and 
right atrial area (RAA), while NT-proBNP only correlates 
significantly with RVSP and RAA.
Discussion
Our study has shown a correlation between soluble ST2 
and RVSP, RVDD and RAA, supporting a previous report 
in a cohort of HF secondary to ischemic heart disease and 
idiopathic dilated cardiomyopathy.13 Therefore, the relation-
ship between ST2 and RVSP is not only restricted to both 
ischemic heart disease and idiopathic dilated cardiomyopa-
thy but extends to hypertensive HF. We did not however find 
any correlation between soluble ST2 and tricuspid annular 
plane excursion. This finding has to be further verified in 
a larger cohort. Although NT-proBNP correlated well with 
RVSP and RAA, there was poor correlation with RVDD, 
which may suggest that soluble ST2 is a better circulating 
biomarker than the more traditional NT-proBNP in assess-
ing hypertensive HF.
On linear regression analysis, factors that were associated 
with abnormal RV function included dilated left atrium and 
LV, increased LV mass, reduced LV systolic function, restric-
tive filling pattern and RVSP. LV dilation has been previously 
shown to have an impact on RV function as measured by 
TAPSE.14 It has been previously shown that a reduced LVEF 
impacts on TAPSE even in the setting of preserved RV ejec-
tion fraction.14,15 The effect of LVEF on TAPSE has been 
attributed to ventricular interdependence.16
The finding in our study of an inverse relationship 
between RV systolic function and RVSP is in accordance with 
most previous studies.17 This relationship has been reported 
in patients with dilated cardiomyopathy and ischemic heart 
diseases, supporting the fact that the major determinant of 
RV systolic function in left-sided HF is after load mismatch 
due to increase in pulmonary artery resistance.17 TAPSE 
Table 3 Univariate analysis with RV systolic function using TAPSE
Parameters Pearson correlation p-value
Left atrial diameter
-0.54 <0.0001
EDD
-0.47 <0.0001
ESD
-0.55 <0.0001
LVM/HT2.7
-0.34 <0.0001
LVEF 0.60 <0.0001
ME/MA
-0.39 <0.0001
Left atrial area
-0.24 0.02
RAA
-0.44 <0.0001
RVSP
-0.74 <0.0001
RVDD
-0.035 0.77
Soluble ST2 0.04 0.68
NT-proBNP 0.000 0.99
Abbreviations: RV, right ventricular; TAPSE, tricuspid annular plane systolic 
excursion; EDD, end-diastolic diameter; ESD, end-systolic diameter; HT, height; 
LVM, left ventricular mass; LVEF, left ventricular ejection fraction; ME, early mitral 
inflow; MA, late mitral inflow; RAA, right atrial area; RVSP, right ventricular systolic 
pressure; RVDD, right ventricular diameter in diastole.
Table 4 Univariate and multivariate associations between log-transformed ST2 and echocardiography right-sided parameters
Univariate association Multivariate association
Parameters Serum ST2, R1 NT-proBNP, R2 Standard coefficient (b) p-value
RVSP 0.75* 0.54** 0.46 <0.001
RAA 0.46* 0.20** 034 0.003
RVDD 0.28* 0.09 – –
TAPSE
-0.15 -0.13 – –
Notes: R1, coefficient of correlation between soluble ST2 and variables; R2, coefficient of correlation between NT-proBNP and variables. *p<0.05 versus soluble ST2. 
**p<0.05 versus NT-proBNP.
Abbreviations: RVSP, right ventricular systolic pressure; RAA, right atrial area; RVDD, right ventricular diameter in diastole; TAPSE, tricuspid annular plane systolic 
excursion.
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correlated with markers of diastolic dysfunction and RVSP 
in our study but not with RV end-diastolic diameter as previ-
ously reported.18
We found RV systolic dysfunction (measured by TAPSE) 
in 33 of the 77 subjects studied. The high prevalence of RV 
systolic dysfunction in our hypertensive HF cohort might 
partly explain the poor prognosis that is found in our sub-
jects,19 as RV systolic dysfunction is a poor prognostic factor 
in HF.16,17 There is a need therefore to pay more attention to 
RV function, which has often been neglected in hypertensive 
HF subjects. The impairment of RV function in left-sided HF 
has been linked to ventricular interdependence,18 which is 
always present in HF, being most apparent with changes in 
loading conditions such as those seen with volume loading.15
Limitation
Since our study is limited by the number of subjects, the 
relationship between plasma ST2 and echocardiographic 
variables seen in this study should be viewed as hypothesis 
generating for studies in larger patient cohorts. In addition, 
RV function was only assessed by TAPSE and not by other 
parameters such as TAPSE/pulmonary arterial systolic pres-
sure (PAPS) and fractional area change (FAC). In addition, 
since the diagnosis of ischemic heart was made clinically 
using history, troponin I levels and electrocardiography with 
no myocardial perfusion imaging and coronary angiography 
performed, it is possible that subtle coronary artery disease 
might have been missed, which is a confounding factor as 
ischemic heart disease increases the concentration of soluble 
ST2.2,3 However, the careful and extensive phenotyping of 
our study population with respect to clinical, echocardio-
graphic and biochemical parameters must have reduced the 
effect of these limitations and is, therefore, a strong point 
in this study.
Conclusion
A higher concentration of soluble ST2 correlates with higher 
RVSP in a cohort of hypertensive HF. Therefore, the asso-
ciation of ST2 with RVSP is not only limited to HF due to 
ischemic heart disease and idiopathic dilated cardiomyopathy 
but also HF secondary to hypertensive heart disease.
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